Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MYLAN

  • FDA Approval
  • Feb. 22, 2024, 10:06 UTC
  • 40
  • 0 comments

FDA approve TOBRAMYCIN

Comment Full text

AMNEAL PHARMS CO

  • FDA Approval
  • Feb. 22, 2024, 10:06 UTC
  • 41
  • 0 comments

FDA approve URSODIOL

Comment Full text

WATSON LABS TEVA

  • FDA Approval
  • Feb. 22, 2024, 10:06 UTC
  • 35
  • 0 comments

FDA approve ESTROPIPATE

Comment Full text

RUBICON

  • FDA Approval
  • Feb. 22, 2024, 10:06 UTC
  • 42
  • 0 comments

FDA approve NITROGLYCERIN

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • Feb. 22, 2024, 10:06 UTC
  • 41
  • 0 comments

FDA approve EZETIMIBE

Comment Full text

SOMERSET THERAPS LLC

  • FDA Approval
  • Feb. 22, 2024, 10:06 UTC
  • 44
  • 0 comments

FDA approve TOBRAMYCIN

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Feb. 22, 2024, 10:06 UTC
  • 46
  • 0 comments

FDA approve TERIFLUNOMIDE

Comment Full text

PFIZER

  • FDA Approval
  • Feb. 22, 2024, 10:06 UTC
  • 45
  • 0 comments

FDA approve ESTROPIPATE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Feb. 22, 2024, 05:19 UTC
  • 43
  • 0 comments

FDA approve SOLIFENACIN SUCCINATE

Comment Full text

BIONPHARMA

  • FDA Approval
  • Feb. 21, 2024, 10:03 UTC
  • 45
  • 0 comments

FDA approve CARBAMAZEPINE

Comment Full text
  • Previous
  • 544
  • 545
  • 546
  • 547
  • 548
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328517)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183573)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin